Positive results in preclinical research don't always equate to success in the clinic. To bridge the translation gap, animal... Read More
Positive results in preclinical research don't always equate to success in the clinic. To bridge the translation gap, animal... Read More
Even as new vaccines roll out globally, the drug discovery work on COVID-19 is far from over. In an... Read More
Critical Jh Syngeneic Tumor Model Host Now Available on a B6 Background Rensselaer, NY — January 18, 2021 -... Read More
Rolling out safe, efficacious COVID-19 vaccines worldwide will be a formidable challenge that will take time, causing many more... Read More
New Random Integration Transgenic Animal Model Generation Solution Available Rensselaer, NY — December 3, 2020 - Taconic Biosciences, a... Read More
Mouse models are playing an integral role in COVID-19 drug discovery, both for vaccines and targeted therapeutics. In an... Read More
Immediate availability of hACE2 mouse Rensselaer, NY — October 26, 2020 - Taconic Biosciences, a global leader in providing... Read More
Aged models are vital for studying neurodegenerative diseases that develop later in life, but managing these colonies proves challenging.... Read More
Humanized immune system (HIS) models have demonstrated utility in early-stage drug discovery across a range of therapeutic areas. In... Read More
Research into COVID-19 is rapidly evolving, and Taconic Biosciences' Dr. Megan MacBride explains in a recent article in Drug... Read More
Welcome! Tell us a little about yourself